))
Nutromics – Better healthcare by way of continuous molecular monitoring
Manage episode 323861910 series 3007793
Content provided by Artesian. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Artesian or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
We talk to Australian MedTech company Nutromics’ Co-founders and Co-CEOs, Hitesh Mehta and Peter Vranes.
Nutromics is aiming to transform healthcare by bringing continuous molecular monitoring (CMM) to market. We discuss our existing healthcare system’s reliance on blood draws for analysis, as well as the new CMM biosensors being developed by Nutromics that provide real-time molecular data to clinicians and patients. Find out how these small, wearable patches can improve the patient experience and even save lives by speeding up clinical analysis and assisting with pre-symptomatic diagnosis.
https://www.nutromics.com.au/
This is episode 11 of the ArteHouse Innovation Series with Ali & Tim.
23 episodes
Share
